Tryozi review

Take a quarter dose here and you pay the full-dose rate — Tryozi says so in the reader's own words, on the same page as everything else. And that page is genuinely better than most: the intro price, its four-week limit, the standing rate and the prepay ladder all sit together, the FDA question is answered with a flat no rather than a hedge, and all four compounding pharmacies are named with an explicit invitation to go and check them. That last part is rare enough to be worth switching for, if the structure suited you. It does not suit someone taking less. Two things will cost you if you misread them. The advertised figure buys four weeks and then doubles. And the prepay discounts are published as percentages off the monthly rate rather than as prices, so the cheapest rung is a number you have to work out rather than one you can read.

Vs median

$104/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

Tryozi names its pharmacy: RedRock · Health Warehouse · Precision Medicine · Triad Rx. No bloodwork is required before you start. A clinician review is included in the price.

Tryozi sells compounded semaglutide and compounded tirzepatide as weekly injections in all 50 states and Washington DC, with the flat-dose rule, the introductory price, the standing rate and the prepay ladder all on one page. It names all four of its 503A compounding pharmacies and invites the reader to check them: "Our 503A pharmacy partners are listed by name, RedRock, Health Warehouse, Precision Medicine, Triad Rx, so you can verify who prepares your medication for yourself." It displays a LegitScript seal number, answers the FDA question without hedging, and is registered as Tryozi Group LLC in Pembroke Pines, Florida.

ONE PRICE AT EVERY DOSE. A patient deliberately holding a quarter dose pays the same $279 as one at the top of the range

• THE ADVERTISED $139 BUYS FOUR WEEKS. The standing rate is $279, twice as much, and the intro is bounded in weeks while the standing rate is quoted per month
• The prepay rungs are published only as percentages — 22%, 29% and 47% off — so the actual figures are printed nowhere
• No milligram range is published against the flat price, so the upper bound of what "any dose" covers is unstated
• Which of the four named pharmacies fills a given order, and on what basis, is not published
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Tryozi is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan